BeNeLuxBelgiumNetherlandsLuxembourg

Prosensa and GlaxoSmithKline expand Duchenne dystrophy alliance

24.06.2010

Leiden - Prosensa NV and British drugmaker GlaxoSmithKline have expanded their cooperation concerning RNA-modulating drugs against Duchenne muscular dystrophy (DMD). Two programmes, covering 4 drug new drug candidates for specific patient subpopulations, have been added to the existing collaboration in DMD. According to the terms of the agreement, GSK has paid two upfront fees and will add milestones dependant on research progress. Within the new programmes, Prosensa and GSK will focus on the skipping of four exons (exon 45, 52, 53, and 55), in addition to their existing programmes that target skipping of exon 51 and 44 (PRO051/GSK2402968 and PRO044). GSK has an option to select two of these additional four compounds for later-stage development and commercialization. Prosensa will retain certain limited European commercialisation rights alongside GSK for the two compounds selected by GSK. For the two compounds not selected by GSK, Prosensa will retain full commercialization rights.

BeNeLuxBelgiumNetherlandsLuxembourg

22.11.2007

Ghent – Novartis and Innogenetics have settled a patent litigation suit, giving Innogenetics non-exclusive rights to continue to develop and commercialize HCV immunodiagnostics in undisclosed European countries. Chiron Corp., now...

BeNeLuxBelgiumNetherlandsLuxembourg

22.11.2007

Leiden – Pharming has raised a70 million in a private placement of convertible bonds due in 2012. The company will buy back royalty rights to future revenues from four Pharming products, thereby ending a 2006 deal with Paul...

BeNeLuxBelgiumNetherlandsLuxembourg

22.11.2007

Liege – Molecular diagnostics com-pany Oncomethylome Sciences (Belgium) has increased its capital with the sup­port of “institutional and qualified investors”. The volume of the placing for the gene methylation specialist was...

BeNeLuxBelgiumNetherlandsLuxembourg

22.11.2007

Leiden – The results from Crucell N.V.’s phase I study with a monoclonal antibody cocktail against rabies suggest that the product candidate was well tolerated by the patients, in dose escalation as well as in combination with...

BeNeLuxBelgiumNetherlandsLuxembourg

20.11.2007

Leuven – Integrated DNA Technologies, the largest US supplier of custom oligonucleotides, will expand its services in Europe and is to open a new production facility at its European daughter company IDT BVBA in Belgium. IDT’s...

BeNeLux, FinlandBelgiumNetherlandsLuxembourg

04.10.2007

Kuipio/Helsinki – Two Finnish biotech companies have succeed in attracting investments of several million euros. Brain diagnostics firm Nexstim Ltd, whichbased in Helsinki, has announced an €8 million financing round with LSP...

BeNeLuxBelgiumNetherlandsLuxembourg

26.09.2007

Ghent - Hepatocellular carcinoma is very difficult to detect, and it is a major cause of death in Asia and Africa, with rising incidence in Western countries. Now, researchers under Liesbeth Desmyter at the VIB, Flanders...

Germany, BeNeLuxBelgiumNetherlandsLuxembourg

24.09.2007

Ghent – Boehringer Ingelheim and Ablynx NV have extended their large research and development deal. In January, the Belgian biopharmaceutical company and the German pharma firm signed an exclusive global collaboration potentially...

BeNeLuxBelgiumNetherlandsLuxembourg

24.09.2007

Amsterdam – Agendia BV has raised €25 million in a fourth financing round. ING, one of the largest bank insurers, becomes a shareholder of Agendia, a molecular diagnostics company that develops and provides highly specific cancer...

BeNeLuxBelgiumNetherlandsLuxembourg

24.09.2007

Brussels – The 386 laboratories in Belgium licensed to carry out biomedical experiments involving animals used 756,715 animals last year, which is a slight increase from the previous year. Federal public authorities note that 92%...

Displaying results 181 to 190 out of 304

< Previous 181-190 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-benelux/browse/18/article/prosensa-and-glaxosmithkline-expand-duchenne-dystrophy-alliance.html

Product of the week

Products

Events

All Events

Current issue

All issues